Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Market Report Forecast 2017-2021

May 2017 | 126 pages | ID: GDC50BC4F9AEN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Bayer HealthCare
AngioCure
AVIDAL Vascular GmbH
AnGes MG
Contego Medical
Elixir Medical
eucatech AG
Lifetech Scientific
Medtronic

Product Segment Analysis:

• Type 1
• Type 2
• Type 3

Application Segment Analysis:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS MARKET OVERVIEW

1.1 Product Overview and Scope of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
1.2 Classification of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (2012-2021)
  1.5.1 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2021)
  1.5.2 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS MANUFACTURING COST ANALYSIS

3.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Competition by Manufacturers
  5.1.1 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Share by Manufacturers (2012-2017)
5.2 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume and Value) by Type
  5.5.1 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type (2012-2017)
  5.5.2 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Type (2012-2017)
5.3 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume and Value) by Regions
  5.3.1 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Regions (2012-2017)
5.4 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons (Volume) by Application

6 UNITED STATES PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS (VOLUME, VALUE AND SALES PRICE)

6.1 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
  6.1.1 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
  6.1.2 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
  6.1.3 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
6.2 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
6.3 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
6.4 United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application

7 CHINA PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS (VOLUME, VALUE AND SALES PRICE)

7.1 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
  7.1.1 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
  7.1.2 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
  7.1.3 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
7.2 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
7.3 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
7.4 China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application

8 EUROPE PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
  8.1.1 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
  8.1.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
8.2 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
8.3 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
8.4 Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application

9 JAPAN PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Value (2012-2017)
  9.1.1 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
  9.1.2 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
9.2 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Manufacturers
9.3 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type
9.4 Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application

10 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS MANUFACTURERS ANALYSIS

10.1 Bayer HealthCare
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 AngioCure
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 AVIDAL Vascular GmbH
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 AnGes MG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Contego Medical
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Elixir Medical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 eucatech AG
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Lifetech Scientific
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Medtronic
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

...

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL PERIPHERAL TRANSLUMINAL ANGIOPLASTY PERIPHERAL DRUG ELUTING BALLOONS MARKET FORECAST (2017-2021)

13.1 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue Forecast (2017-2021)
13.2 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Regions (2017-2021)
13.3 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Type (2017-2021)
13.4 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES
Figure Picture of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Table Classification of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Global Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type in 2015
Table Applications of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Global Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Application in 2015
Figure United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2021)
Figure China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2021)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2021)
Figure Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2021)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2021)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2021)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales of Key Manufacturers (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers (2012-2017)
Figure 2015 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers
Figure 2016 Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Manufacturers
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue by Manufacturers (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers
Table 2016 Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Manufacturers
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Type (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Type (2012-2017)
Figure Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type (2012-2017)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Type (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Type (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Type (2012-2017)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Growth Rate by Type (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Regions (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Regions (2012-2017)
Figure Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Regions (2012-2017)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Regions (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Market Share by Regions (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Regions (2012-2017)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue Growth Rate by Regions (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Market Share by Application (2012-2017)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Share by Application (2012-2017)
Figure Sales Market Share of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons by Application (2012-2017)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Growth Rate by Application (2012-2017)
Figure United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2012-2017)
Table United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2012-2017)
Table United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2012-2017)
Table United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2012-2017)
Table United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2012-2017)
Table United States Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2012-2017)
Figure China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2012-2017)
Table China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2012-2017)
Table China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2012-2017)
Table China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2012-2017)
Table China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2012-2017)
Table China Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2012-2017)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2012-2017)
Table Europe Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2012-2017)
Figure Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate (2012-2017)
Figure Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate (2012-2017)
Figure Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Price Trend (2012-2017)
Table Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Manufacturers (2012-2017)
Table Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Manufacturers (2012-2017)
Table Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Type (2012-2017)
Table Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Type (2012-2017)
Table Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales by Application (2012-2017)
Table Japan Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Market Share by Application (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer HealthCare Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table AngioCure Basic Information List
Table AngioCure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AngioCure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table AVIDAL Vascular GmbH Basic Information List
Table AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AVIDAL Vascular GmbH Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table AnGes MG Basic Information List
Table AnGes MG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AnGes MG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table Contego Medical Basic Information List
Table Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Contego Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table Elixir Medical Basic Information List
Table Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Elixir Medical Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table eucatech AG Basic Information List
Table eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure eucatech AG Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table Lifetech Scientific Basic Information List
Table Lifetech Scientific Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Lifetech Scientific Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table Medtronic Basic Information List
Table Medtronic Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Medtronic Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Manufacturing Process Analysis of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Figure Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Industrial Chain Analysis
Table Raw Materials Sources of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Major Manufacturers in 2015
Table Major Buyers of Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons
Table Distributors/Traders List
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales and Growth Rate Forecast (2017-2021)
Figure Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Revenue and Growth Rate Forecast (2017-2021)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Regions (2017-2021)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Type (2017-2021)
Table Global Peripheral Transluminal Angioplasty Peripheral Drug Eluting Balloons Sales Forecast by Application (2017-2021)